Abstract
In Reply. —Regarding the suggestions of Dr Chaulk and colleagues: Amen! As indicated by a recent article published elsewhere, 1 I firmly believe that broad application of DOT is the only realistic tool to prevent worsening of the TB situation. Their data regarding the impact of DOT provide tangible affirmation of the value of this strategy. Dr Pierce and Ms Denison raise an appropriate issue: whether the rise of optic neuritis from ethambutol use is sufficiently great in elderly patients to contravene the routine use of this drug in patients with proven or suspected TB. There are several variables that bear on this problem: The incidence of EAON in their series was far higher than previously reported. Although they noted the calculated dosage and duration of ethambutol treatment, they did not provide information about renal function that might influence the risk of EAON. They note that some of their patients
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
